EVOLUTION BIO Trademark

Trademark Overview


On Tuesday, November 12, 2024, a trademark application was filed for EVOLUTION BIO with the United States Patent and Trademark Office. The USPTO has given the EVOLUTION BIO trademark a serial number of 98848881. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, February 26, 2026. This trademark is owned by Evolution Bio, Inc.. The EVOLUTION BIO trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Protein engineering services, namely, the recombination of genes customized to the specification of others to produce novel gene sequences for use in science, research, and medicine

Development of pharmaceutical preparations and medicines; research and development in the biotechnology field; research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; research and development of pharmaceutical preparations and substances for use in clinical trials; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drugs, materials, and molecular development; software as a service (saas) services featuring computer software platforms for use in optimizing drugs, materials, and molecular discovery; platform as...

Mixed biological preparations for the prevention and treatment of infectious diseases; therapeutic pharmaceuticals for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, as well as cancer and transplant rejections
evolution bio

General Information


Serial Number98848881
Word MarkEVOLUTION BIO
Filing DateTuesday, November 12, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, February 26, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 1, 2025

Trademark Statements


Goods and ServicesProtein engineering services, namely, the recombination of genes customized to the specification of others to produce novel gene sequences for use in science, research, and medicine
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; research and development in the biotechnology field; research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; research and development of pharmaceutical preparations and substances for use in clinical trials; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drugs, materials, and molecular development; software as a service (saas) services featuring computer software platforms for use in optimizing drugs, materials, and molecular discovery; platform as a service (paas) featuring computer software platforms for use in optimizing drugs, materials, and molecular discovery
NOT AVAILABLEBIO
Goods and ServicesMixed biological preparations for the prevention and treatment of infectious diseases; therapeutic pharmaceuticals for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, as well as cancer and transplant rejections

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, November 12, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 12, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEvolution Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPark City, UT 84098
US

Party NameEvolution Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPark City, UT 84098
US

Trademark Events


Event DateEvent Description
Tuesday, November 12, 2024NEW APPLICATION ENTERED
Tuesday, November 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 16, 2025ASSIGNED TO EXAMINER
Monday, April 21, 2025NON-FINAL ACTION WRITTEN
Monday, April 21, 2025NON-FINAL ACTION E-MAILED
Monday, April 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 12, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 12, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 12, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 27, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 25, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 1, 2025PUBLISHED FOR OPPOSITION
Tuesday, July 1, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 26, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 26, 2026SOU TEAS EXTENSION RECEIVED
Thursday, February 26, 2026SOU EXTENSION 1 FILED
Thursday, February 26, 2026SOU EXTENSION 1 GRANTED
Friday, February 27, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED